T
Travis Craddock
2
APPEARANCES
2
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
Sep 1, 2026
How Computational Biology Is Changing Disease Research with Travis Craddock, Ph.D.
24:40
24:50
25:07
25:40


Travis CraddockGUEST
what they do now is, you know, when you take a blood sample or, you know, saliva sample or whatever sample it is, when they analyze it, they're measuring everything that's in there.

Travis CraddockGUEST
And so the idea then is you take that that level of data, it comes in and you would have some sort of AI process which would go through and either come through the data, try and cluster it to, you know, pick out this is what's different in the illness group versus what's different in the control group.

Travis CraddockGUEST
using whatever algorithms are available once you identify that the bottleneck that we have right now is transforming that this is what we see is different into an actual model so how does you know a b cell talk to a t cell with a given um you know inflammatory mediator a given cytokine signal and so forth You know, what happens when a given cytokine like TNF-alpha, you know, interacts with a T cell and what does the T cell do? And there's reams and reams of literature that's out there.

Travis CraddockGUEST
So what we want to do is take that data that, you know, what we found that's different in the illness group from the control group from the omics.
6 MINS LATER
How Computational Biology Is Changing Disease Research with Travis Craddock, Ph.D.
24:40
24:50
25:07
25:40

Travis CraddockGUEST
what they do now is, you know, when you take a blood sample or, you know, saliva sample or whatever sample it is, when they analyze it, they're measuring everything that's in there.

Travis CraddockGUEST
And so the idea then is you take that that level of data, it comes in and you would have some sort of AI process which would go through and either come through the data, try and cluster it to, you know, pick out this is what's different in the illness group versus what's different in the control group.

Travis CraddockGUEST
using whatever algorithms are available once you identify that the bottleneck that we have right now is transforming that this is what we see is different into an actual model so how does you know a b cell talk to a t cell with a given um you know inflammatory mediator a given cytokine signal and so forth You know, what happens when a given cytokine like TNF-alpha, you know, interacts with a T cell and what does the T cell do? And there's reams and reams of literature that's out there.

Travis CraddockGUEST
So what we want to do is take that data that, you know, what we found that's different in the illness group from the control group from the omics.
6 MINS LATER
